Literature DB >> 2985306

Biochemical and physiochemical characteristics of a pre-B cell stimulating factor produced by the plasmacytoma cell line LICR LON HMY2.

A Trudgett, A C Fay, J M Thompson, T A McNeill.   

Abstract

We have characterized the pre-B cell colony stimulating activity (pre-B cell CSA) from LICR LON HMY2 conditioned medium (CM) by a variety of biochemical techniques. Pre-B cell CSA was found to be associated with a heat stable glycoprotein which has an isoelectric point of 8.3 and a mol. wt, as determined by polyacrylamide gel electrophoresis, of 28-32 kD. The relationship of this activity to previously described factors acting on cells of the B cell lineage is discussed.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2985306      PMCID： PMC1576943     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  18 in total

1.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

2.  A transplantable myelomonocytic leukemia in BALB-c mice: cytology, karyotype, and muramidase content.

Authors:  N L Warner; M A Moore; D Metcalf
Journal:  J Natl Cancer Inst       Date:  1969-10       Impact factor: 13.506

Review 3.  Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men.

Authors:  G Klein
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

4.  Characterization of human B cell growth factor (BCGF) from cloned T cells or mitogen-stimulated T cells.

Authors:  K Yoshizaki; T Nakagawa; K Fukunaga; T Kaieda; S Maruyama; S Kishimoto; Y Yamamura; T Kishimoto
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

5.  A human-hybridoma system based on a fast-growing mutant of the ARH-77 plasma cell leukemia-derived line.

Authors:  P A Edwards; C M Smith; A M Neville; M J O'Hare
Journal:  Eur J Immunol       Date:  1982-08       Impact factor: 5.532

6.  Purification of human platelet-derived growth factor.

Authors:  H N Antoniades; C D Scher; C D Stiles
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

7.  Constitutive production of a unique lymphokine (IL 3) by the WEHI-3 cell line.

Authors:  J C Lee; A J Hapel; J N Ihle
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

8.  T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF.

Authors:  A Muraguchi; T Kishimoto; Y Miki; T Kuritani; T Kaieda; K Yoshizaki; Y Yamamura
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

9.  Procedures for the purification of interleukin 3 to homogeneity.

Authors:  J N Ihle; J Keller; L Henderson; F Klein; E Palaszynski
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

10.  Enrichment (and depletion) of human suppressor cells with monoclonal antibodies and immunoglobulin-coated plates.

Authors:  M S Tsoi; J Aprile; S Dobbs; S Goehle; R Storb
Journal:  J Immunol Methods       Date:  1982-09-30       Impact factor: 2.303
View more
  3 in total

1.  Growth of human B cell colonies from peripheral blood of patients with systemic lupus erythematosus.

Authors:  A C Fay; S Price; A Trudgett; J D McCrea; M Haire; M W Boyd; T A McNeill
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103

2.  Detection and partial characterization of human B cell colony stimulating activity in synovial fluids of patients with rheumatoid arthritis.

Authors:  A C Fay; A Trudgett; J D McCrea; F Kirk; J M Thompson; E S Mitchell; M J Boyd; S D Roberts; T A McNeill
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

3.  A search for retrovirus infection in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  B K Pelton; M North; R G Palmer; W Hylton; C Smith-Burchnell; A L Sinclair; M Malkovsky; A G Dalgleish; A M Denman
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.